Ameriprise’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-94,543
| Closed | -$2.26M | – | 4028 |
|
2021
Q1 | $2.26M | Sell |
94,543
-360,151
| -79% | -$8.61M | ﹤0.01% | 2808 |
|
2020
Q4 | $6.64M | Sell |
454,694
-285,429
| -39% | -$4.17M | ﹤0.01% | 2062 |
|
2020
Q3 | $10.5M | Buy |
740,123
+1,501
| +0.2% | +$21.3K | ﹤0.01% | 1527 |
|
2020
Q2 | $10.9M | Buy |
738,622
+675,250
| +1,066% | +$9.94M | ﹤0.01% | 1481 |
|
2020
Q1 | $262K | Buy |
63,372
+6,649
| +12% | +$27.5K | ﹤0.01% | 3355 |
|
2019
Q4 | $273K | Buy |
56,723
+15,614
| +38% | +$75.1K | ﹤0.01% | 3505 |
|
2019
Q3 | $249K | Buy |
+41,109
| New | +$249K | ﹤0.01% | 3492 |
|
2019
Q2 | – | Sell |
-51,986
| Closed | -$369K | – | 3789 |
|
2019
Q1 | $369K | Sell |
51,986
-61,189
| -54% | -$434K | ﹤0.01% | 3368 |
|
2018
Q4 | $550K | Buy |
+113,175
| New | +$550K | ﹤0.01% | 3148 |
|
2017
Q3 | – | Sell |
-43,141
| Closed | -$510K | – | 3769 |
|
2017
Q2 | $510K | Buy |
43,141
+9,196
| +27% | +$109K | ﹤0.01% | 3223 |
|
2017
Q1 | $435K | Buy |
+33,945
| New | +$435K | ﹤0.01% | 3213 |
|
2014
Q4 | – | Sell |
-331
| Closed | -$3K | – | 4640 |
|
2014
Q3 | $3K | Sell |
331
-356,356
| -100% | -$3.23M | ﹤0.01% | 5280 |
|
2014
Q2 | $4.83M | Sell |
356,687
-168,992
| -32% | -$2.29M | ﹤0.01% | 2099 |
|
2014
Q1 | $5.23M | Buy |
525,679
+252,139
| +92% | +$2.51M | ﹤0.01% | 1988 |
|
2013
Q4 | $3.64M | Buy |
273,540
+271,304
| +12,133% | +$3.61M | ﹤0.01% | 2186 |
|
2013
Q3 | $27K | Buy |
2,236
+421
| +23% | +$5.08K | ﹤0.01% | 4211 |
|
2013
Q2 | $19K | Buy |
+1,815
| New | +$19K | ﹤0.01% | 4322 |
|